Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Oppenheimer Maintains Outperform on C3.ai, Maintains $40 Price Target

Author: Benzinga Newsdesk | September 05, 2024 01:49pm
Oppenheimer analyst Timothy Horan maintains C3.ai (NYSE:AI) with a Outperform and maintains $40 price target.

Posted In: AI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist